Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 32Unknown 17Recruiting 16Terminated 7Active not recruiting 7Not yet recruiting 2Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 9Rectal Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Glioblastoma 4Esophageal Neoplasms 4Neoplasms 3Nasopharyngeal Carcinoma 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma 2Spinal Cord Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Rhabdomyosarcoma 1Rectal Cancer Patients 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1

Interventions

toripalimab 6130-nm albumin-bound paclitaxel 6Cisplatin 5Drug Therapy 4tislelizumab 3sintilimab 3camrelizumab 3Immune Checkpoint Inhibitors 3Fluorouracil 3Carboplatin 3nedaplatin 2anlotinib 2Radiotherapy 2Neoadjuvant Therapy 2Esophagectomy 2Capecitabine 2potassium oxonate 1pembrolizumab 1lenvatinib 1ivarmacitinib 1irinotecan sucrosofate 1fluzoparib 1Watchful Waiting 1TP protocol 1S 1 (combination) 1Radiotherapy, Intensity-Modulated 1Radiation 1Paclitaxel 1Observation 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Squamous Cell Carcinoma × Radiotherapy × Clear all
NCT05791136 2023-03-30

TREE

The Central Hospital of Lishui City

Phase 2 Not yet recruiting
30 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05244798 2022-10-25

Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

Sichuan Cancer Hospital and Research Institute

Phase 3 Not yet recruiting
420 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡